• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德克萨斯药物算法项目:药物算法的定义、原理及开发方法

Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms.

作者信息

Gilbert D A, Altshuler K Z, Rago W V, Shon S P, Crismon M L, Toprac M G, Rush A J

机构信息

Texas Department of Mental Health and Mental Retardation, Austin, USA.

出版信息

J Clin Psychiatry. 1998 Jul;59(7):345-51.

PMID:9714262
Abstract

BACKGROUND

The Texas Medication Algorithm Project (TMAP), a public-academic collaborative effort, is a 3-phase project to develop, implement, and evaluate medication treatment algorithms for public sector patients with schizophrenia, major depressive disorders, or bipolar disorders.

DISCUSSION

This paper, the first in a series describing the activities of the TMAP, focuses on the various definitions and reasons why guidelines have gained popularity. Also discussed are their strengths, the limitations of the various methods used to develop them, and potential barriers to their implementation.

摘要

背景

德克萨斯药物治疗算法项目(TMAP)是一项公共-学术合作项目,是一个分三个阶段的项目,旨在为患有精神分裂症、重度抑郁症或双相情感障碍的公共部门患者开发、实施和评估药物治疗算法。

讨论

本文是描述TMAP活动系列文章中的第一篇,重点关注各种定义以及指南广受欢迎的原因。还讨论了指南的优势、制定指南所使用的各种方法的局限性以及实施指南的潜在障碍。

相似文献

1
Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms.德克萨斯药物算法项目:药物算法的定义、原理及开发方法
J Clin Psychiatry. 1998 Jul;59(7):345-51.
2
Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder.德克萨斯药物算法项目:双相情感障碍患者治疗算法的开发与可行性测试
J Clin Psychiatry. 2001 Jun;62(6):439-47.
3
Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.严重及持续性精神疾病的药物治疗:德克萨斯药物治疗算法项目
J Clin Psychiatry. 1999 May;60(5):284-91. doi: 10.4088/jcp.v60n0503.
4
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder.德克萨斯药物治疗算法项目:德克萨斯关于重度抑郁症药物治疗共识会议小组报告
J Clin Psychiatry. 1999 Mar;60(3):142-56.
5
Mental health care from the public perspective: the Texas Medication Algorithm Project.
J Clin Psychiatry. 1999;60 Suppl 3:16-20; discussion 21.
6
Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.2000年德克萨斯双相情感障碍药物治疗共识会议小组报告。
J Clin Psychiatry. 2002 Apr;63(4):288-99. doi: 10.4088/jcp.v63n0404.
7
Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.德克萨斯药物治疗算法项目,第3阶段(TMAP - 3):基本原理与研究设计。
J Clin Psychiatry. 2003 Apr;64(4):357-69. doi: 10.4088/jcp.v64n0402.
8
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.德克萨斯药物治疗算法项目中重度抑郁症患者的临床结果。
Arch Gen Psychiatry. 2004 Jul;61(7):669-80. doi: 10.1001/archpsyc.61.7.669.
9
The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms.德克萨斯药物治疗算法项目(TMAP)精神分裂症算法
J Clin Psychiatry. 1999 Oct;60(10):649-57. doi: 10.4088/jcp.v60n1002.
10
Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project.医疗服务提供者对治疗指南的遵循是否会改变双相情感障碍患者的临床结局?德克萨斯药物算法项目的结果。
Psychol Med. 2005 Dec;35(12):1695-706. doi: 10.1017/S0033291705005933. Epub 2005 Sep 29.

引用本文的文献

1
Dentate gyrus activin signaling mediates the antidepressant response.齿状回激活素信号转导介导抗抑郁反应。
Transl Psychiatry. 2021 Jan 7;11(1):7. doi: 10.1038/s41398-020-01156-y.
2
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines.国际神经精神药理学学院成人双相障碍治疗指南(CINP-BD-2017),第 3 部分:临床指南。
Int J Neuropsychopharmacol. 2017 Feb 1;20(2):180-195. doi: 10.1093/ijnp/pyw109.
3
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.
《国际神经精神药理学学院成人双相情感障碍治疗指南(CINP-BD-2017)》第二部分:综述、证据分级和精确算法。
Int J Neuropsychopharmacol. 2017 Feb 1;20(2):121-179. doi: 10.1093/ijnp/pyw100.
4
Evidence-based practices in community mental health: outcome evaluation.社区心理健康中的循证实践:结果评估。
J Behav Health Serv Res. 2012 Oct;39(4):434-44. doi: 10.1007/s11414-012-9284-0.
5
Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.双相障碍的药物治疗疗效:WPA 药物精神医学分会报告。
Eur Arch Psychiatry Clin Neurosci. 2012 Jun;262 Suppl 1:1-48. doi: 10.1007/s00406-012-0323-x.
6
A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder.双相情感障碍患者中临床医生评定的抑郁症状快速量表(QIDS-C16)的心理测量学评估。
Int J Methods Psychiatr Res. 2009 Jun;18(2):138-46. doi: 10.1002/mpr.285.
7
Translating Science Into Service: Lessons Learned From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study.将科学转化为服务:从缓解抑郁症的序贯治疗方案(STAR*D)研究中获得的经验教训。
Prim Care Companion J Clin Psychiatry. 2007;9(5):331-7. doi: 10.4088/pcc.v09n0501.
8
Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.双相情感障碍的治疗:针对一种多方面病症的复杂治疗。
Ann Gen Psychiatry. 2007 Oct 9;6:27. doi: 10.1186/1744-859X-6-27.
9
Manufacturing consensus.
Cult Med Psychiatry. 2006 Jun;30(2):135-56. doi: 10.1007/s11013-006-9013-3.
10
Diagnosing schizophrenia circa 2005: how and why?2005年前后精神分裂症的诊断:方式与原因?
Curr Psychiatry Rep. 2005 Aug;7(4):311-5. doi: 10.1007/s11920-005-0086-4.